Woodfield Pharmaceutical, LLC

FDA Regulatory Profile

Woodfield Pharmaceutical, LLC appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0210-2018, Class II) was initiated on December 12, 2017.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0210-2018Class IICodeine-Guaifenesin Oral Solution 10-100 mg/5 mL Antitussive Expectorant ,16 fl. oz. , Manufactured December 12, 2017